查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1876743

肠道健康和益生菌补充剂市场预测至2032年：按产品、成分、通路、最终用户和地区分類的全球分析

Gut Health & Probiotic Supplements Market Forecasts to 2032 - Global Analysis By Product (Dietary Supplements, Functional Foods, Functional Beverages and Other Products), Ingredient, Distribution Channel, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的一项研究，全球肠道健康和益生菌补充剂市场预计将在 2025 年达到 91 亿美元，并在 2032 年达到 173 亿美元，在预测期内以 9.5% 的复合年增长率增长。

肠道健康和益生菌补充剂指的是消化器官系统的平衡和正常功能，它在消化、营养吸收和免疫防御中发挥关键作用。健康的肠道内栖息着多种有益微生物，它们支持代谢和免疫功能。益生菌补充剂是活性细菌和酵母，它们透过补充有益微生物来恢復和维持这种平衡，从而帮助改善消化、增强免疫力并预防消化器官系统疾病。定期服用益生菌有助于促进肠道菌丛的健康，减少炎症，并支持身体的自然防御机制，从而增进整体健康。

消费者对预防保健和健康产品的需求

在全球范围内，人们对预防保健和改善健康的需求推动了益生菌补充剂的流行。消费者对消化系统健康、免疫力和整体健康的日益重视，促使他们开始每天服用益生菌。机能性食品和补充剂越来越多地被作为综合健康方案的一部分进行推广。健康专家推荐益生菌作为传统治疗方法的辅助手段，进一步提升了其可信度。这种将消费者健康需求与预防性营养结合的趋势，持续推动益生菌产品的成长。

高昂的研发成本和监管障碍使得健康声明面临挑战。

研发成本和监管壁垒限制了益生菌生产商的扩张。开发经临床检验的菌株需要大量投资于测试和配方研发。监管机构对健康声明製定了严格的指导方针，导致产品上市延迟和合规成本增加。由于资源有限，小规模的公司在与现有企业竞争时面临重重障碍。儘管市场需求不断增长，但这些限制因素仍阻碍创新和市场扩张。

与个人化营养和基于DNA的健康理念相结合

个人化营养和基于DNA的健康管理正在提升消费者参与度和产品差异化。企业正在拓展其微生物组检测套组线，并结合个人化订製的益生菌配方。人工智慧驱动的平台能够根据基因和生活方式数据提供个人化建议。膳食补充剂公司与数位健康Start-Ups之间的合作正在加速创新。这项机会正在为益生菌领域开闢新的收入来源，并增强消费者忠诚度。

保质期稳定性和低温运输要求

保存期限稳定性及低温运输要求限制了益生菌产品的分销和价格承受能力。活性益生菌菌株需要受控的储存条件才能维持其功效。新兴市场基础设施​​不足限制了产品的供应和稳定性。高昂的物流成本降低了益生菌产品与传统膳食补充剂相比的竞争力。这些挑战持续阻碍益生菌产品的全球推广和长期普及。

新冠疫情的感染疾病：

新冠感染疾病加速了益生菌的需求，因为消费者更加重视免疫力和预防性保健。疫情加速了已开发市场和新兴市场对益生菌补充剂的接受度。虽然封锁措施扰乱了供应链和分销，但线上管道迅速扩张以弥补损失。各大品牌将行销重点放在免疫力上，并将益生菌定位为必需的健康产品。疫情后的復苏阶段，结合零售和电商的混合分销模式蓬勃发展。这种影响持续改变消费者的行为，并强化了益生菌在预防性保健中的重要角色。

预计在预测期内，膳食补充剂细分市场将占据最大的市场份额。

由于消费者对便捷的日常益生菌摄取需求不断增长，预计膳食补充剂领域在预测期内将占据最大的市场份额。无论是胶囊、片剂或粉末形式的膳食补充剂，都在推动益生菌的普及。消费者青睐补充剂，是因为它们便于携带、剂量精准且易于融入日常生活。健康专家也越来越多地推荐补充剂来促进消化器官系统和免疫健康。零售店和线上通路的广泛普及进一步推动了益生菌的推广。凭藉其便利性和广泛的消费者吸引力，该领域将继续保持主导地位。

预计在预测期内，芽孢桿菌细分市场将呈现最高的复合年增长率。

由于其稳定性和多功能性，芽孢桿菌细分市场预计将在预测期内实现最高成长率。芽孢桿菌菌株正在推动益生菌製剂在膳食补充剂和机能性食品领域的成长。与其他菌株不同，芽孢桿菌能够耐受严苛的加工和储存条件，从而降低对低温运输的依赖。其形成孢子的特性延长了保质期，并增强了其全球分销潜力。对芽孢桿菌在肠道环境和免疫功能方面功效的研究不断深入，正在加速其应用。由于扩充性和韧性，预计该细分市场将超越其他细分市场。

占比最大的地区：

在预测期内，北美预计将凭藉其先进的基础设施和较高的消费者意识占据最大的市场份额。对预防性保健和机能性食品的强劲需求正在推动益生菌的普及。领先的营养保健品公司正在加大研发投入并拓展产品系列。监管环境的明朗化和消费者可支配收入的提高正在推动市场成熟。电子商务的兴起和健康意识行销的普及正在加速益生菌的推广。北美将继续在收入和创新方面保持领先地位。

复合年增长率最高的地区：

在预测期内，亚太地区预计将成为复合年增长率最高的地区，这主要得益于快速的都市化和日益增强的健康意识。中国、日本、印度和东南亚的强劲需求正在推动益生菌市场的成长。本土Start-Ups公司和全球公司正在不断拓展其价格亲民且符合当地文化习惯的益生菌产品线。中产阶级收入的成长和数位技术的普及正在加速市场渗透。政府对预防性医疗保健和营养的支持正在推动益生菌市场的长期成长。

免费客製化服务：

购买此报告的客户可以选择以下免费自订选项之一：

  • 公司概况
    • 对其他市场公司（最多 3 家公司）进行全面分析
    • 对主要企业进行SWOT分析（最多3家公司）
  • 区域细分
    • 根据客户要求，对主要国家的市场规模和复合年增长率进行估算和预测（註：可行性需确认）。
  • 竞争基准化分析
    • 根据主要企业的产品系列、地理覆盖范围和策略联盟基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 研究途径
  • 研究材料
    • 原始研究资料
    • 次级研究资讯来源
    • 先决条件

第三章 市场趋势分析

  • 介绍
  • 司机
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 终端用户分析
  • 新兴市场
  • 新冠疫情的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买方的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球肠道健康和益生菌补充剂市场（按产品划分）

  • 介绍
  • 营养补充品
  • 机能性食品
  • 机能饮料
  • 动物饲料用益生菌
  • 婴儿营养产品
  • 临床营养产品
  • 宠物营养及伴侣动物性产品
  • 其他产品

6. 全球肠道健康和益生菌补充剂市场（按成分划分）

  • 介绍
  • 乳酸菌
  • 双歧桿菌
  • 酿酒酵母
  • 链球菌
  • 芽孢桿菌
  • 肠球菌
  • 其他成分

7. 全球肠道健康和益生菌补充剂市场（按通路管道划分）

  • 介绍
  • 药房和药品商店
  • 超级市场和大卖场
  • 线上平台
  • 专业保健食品店
  • 便利商店和杂货店
  • 其他通路

8. 全球肠道健康和益生菌补充剂市场（按最终用户划分）

  • 介绍
  • 成人
  • 孩子
  • 老年人
  • 兽用
  • 孕妇及哺乳期妇女
  • 其他最终用户

9. 全球肠道健康和益生菌补充剂市场（按地区划分）

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 亚太其他地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十章：重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与併购
  • 新产品上市
  • 业务拓展
  • 其他关键策略

第十一章 企业概况

  • Nestle Health Science
  • Danone SA
  • Chr. Hansen Holding A/S
  • DuPont de Nemours Inc.
  • Kerry Group plc
  • Yakult Honsha Co. Ltd.
  • Amway Corporation
  • Bayer AG
  • BioGaia AB
  • DSM-Firmenich AG
  • Probi AB
  • Arla Foods amba
  • General Mills Inc.
  • NOW Foods
  • Garden of Life LLC
Product Code: SMRC32395

According to Stratistics MRC, the Global Gut Health & Probiotic Supplements Market is accounted for $9.1 billion in 2025 and is expected to reach $17.3 billion by 2032 growing at a CAGR of 9.5% during the forecast period. Gut Health & Probiotic Supplements refer to the balance and proper functioning of the gastrointestinal system, which plays a crucial role in digestion, nutrient absorption, and immune defense. A healthy gut contains a diverse community of beneficial microorganisms that support metabolic and immune functions. Probiotic supplements are live bacteria and yeasts that help restore and maintain this balance by replenishing beneficial microbes. They aid in improving digestion, enhancing immunity, and preventing gastrointestinal disorders. Regular consumption of probiotics contributes to overall wellness by promoting a healthy microbiome, reducing inflammation, and supporting the body's natural defense mechanisms.

Market Dynamics:

Driver:

Consumer demand for preventive healthcare and wellness products

Preventive healthcare and wellness demand is boosting adoption of probiotic supplements globally. Rising awareness of digestive health, immunity, and overall well-being is propelling consumers toward daily probiotic intake. Functional foods and supplements are increasingly marketed as part of holistic wellness routines. Healthcare professionals are recommending probiotics as adjuncts to conventional treatments, further strengthening credibility. This driver continues to anchor growth by aligning consumer health priorities with preventive nutrition.

Restraint:

High R&D costs and regulatory hurdles for health claims

R&D costs and regulatory hurdles are limiting scalability for probiotic manufacturers. Developing clinically validated strains requires significant investment in trials and formulation. Regulatory bodies impose strict guidelines on health claims, delaying product launches and increasing compliance costs. Smaller companies face barriers in competing with established players due to limited resources. This restraint continues to constrain innovation and market expansion despite rising demand.

Opportunity:

Integration with personalized nutrition and DNA-based wellness

Personalized nutrition and DNA-based wellness are enhancing consumer engagement and product differentiation. Companies are increasingly offering microbiome testing kits linked to tailored probiotic formulations. AI-driven platforms are enabling personalized recommendations based on genetic and lifestyle data. Partnerships between nutraceutical firms and digital health startups are accelerating innovation. This opportunity is unlocking new revenue streams and strengthening consumer loyalty in the probiotic sector.

Threat:

Shelf-life stability and cold-chain requirements

Shelf-life stability and cold-chain requirements are constraining distribution and affordability. Live probiotic strains require controlled storage conditions to maintain efficacy. Inadequate infrastructure in emerging markets limits product availability and consistency. High logistics costs reduce competitiveness compared to conventional supplements. This threat continues to challenge global expansion and long-term adoption of probiotics.

Covid-19 Impact:

Covid-19 accelerated demand for probiotics as consumers prioritized immunity and preventive health. Covid-19 boosted probiotic supplement adoption across both developed and emerging markets. Lockdowns disrupted supply chains and distribution, but online channels compensated with rapid growth. Brands leveraged immunity-focused marketing to position probiotics as essential wellness products. Post-pandemic recovery is fostering hybrid distribution models combining retail and e-commerce. This impact continues to reshape consumer behavior and strengthen probiotics' role in preventive healthcare.

The dietary supplements segment is expected to be the largest during the forecast period

The dietary supplements segment is expected to account for the largest market share during the forecast period owing to rising demand for convenient, daily probiotic intake. Dietary supplements are driving adoption of probiotics across capsules, tablets, and powders. Consumers favor supplements for their portability, dosage accuracy, and ease of integration into routines. Healthcare professionals increasingly recommend supplements for digestive and immune health. Expanding retail and online availability is accelerating adoption. This segment continues to dominate due to its accessibility and broad consumer appeal.

The bacillus segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the bacillus segment is predicted to witness the highest growth rate due to its stability and versatility. Bacillus strains are driving growth in probiotic formulations across supplements and functional foods. Unlike other strains, bacillus can withstand harsh processing and storage conditions, reducing cold-chain dependency. Their spore-forming nature enhances shelf-life and global distribution potential. Rising research on bacillus efficacy in gut health and immunity is accelerating adoption. This segment is expected to outpace others due to its scalability and resilience.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share due to advanced infrastructure and high consumer awareness. North America is driving probiotic adoption through strong demand for preventive healthcare and functional foods. Leading nutraceutical companies are investing in R&D and expanding product portfolios. Regulatory clarity and high disposable incomes are fostering market maturity. E-commerce penetration and wellness-focused marketing are accelerating adoption. North America continues to dominate in both revenue and innovation leadership.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR owing to rapid urbanization and rising health consciousness. Asia Pacific is driving probiotic growth through strong demand in China, Japan, India, and Southeast Asia. Local startups and global players are scaling affordable and culturally tailored probiotic products. Rising middle-class incomes and digital adoption are accelerating market penetration. Government support for preventive healthcare and nutrition is fostering long-term growth.

Key players in the market

Some of the key players in Gut Health & Probiotic Supplements Market include Nestle Health Science, Danone S.A., Chr. Hansen Holding A/S, DuPont de Nemours Inc., Kerry Group plc, Yakult Honsha Co. Ltd., Amway Corporation, Bayer AG, BioGaia AB, DSM-Firmenich AG, Probi AB, Arla Foods amba, General Mills Inc., NOW Foods and Garden of Life LLC.

Key Developments:

In June 2025, Danone acquired The Akkermansia Company (TAC), a Belgian biotech pioneer specializing in next-generation biotics, for approximately $200 million. TAC's patented strain Akkermansia muciniphila MucT(TM) has been clinically validated to support gut barrier function, reduce inflammation, and address metabolic disorders such as obesity and diabetes.

In April 2024, Nestle India and Dr. Reddy's Laboratories formed a joint venture to bring nutraceutical and probiotic brands to consumers across India and agreed territories. This collaboration strengthens Nestle's presence in gut health by combining its global nutrition expertise with Dr. Reddy's pharmaceutical distribution network.

Products Covered:

  • Dietary Supplements
  • Functional Foods
  • Functional Beverages
  • Animal Feed Probiotics
  • Infant & Child Nutrition Products
  • Clinical Nutrition Products
  • Pet Nutrition & Companion Animal Products
  • Other Products

Ingredients Covered:

  • Lactobacillus
  • Bifidobacterium
  • Saccharomyces
  • Streptococcus
  • Bacillus
  • Enterococcus
  • Other Ingredients

Distribution Channels Covered:

  • Pharmacies & Drug Stores
  • Supermarkets & Hypermarkets
  • Online Platforms
  • Specialty Health Stores
  • Convenience & Grocery Retailers
  • Other Distribution Channels

End Users Covered:

  • Adults
  • Children
  • Geriatric Population
  • Veterinary Applications
  • Pregnant & Lactating Women
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Gut Health & Probiotic Supplements Market, By Product

  • 5.1 Introduction
  • 5.2 Dietary Supplements
  • 5.3 Functional Foods
  • 5.4 Functional Beverages
  • 5.5 Animal Feed Probiotics
  • 5.6 Infant & Child Nutrition Products
  • 5.7 Clinical Nutrition Products
  • 5.8 Pet Nutrition & Companion Animal Products
  • 5.9 Other Products

6 Global Gut Health & Probiotic Supplements Market, By Ingredient

  • 6.1 Introduction
  • 6.2 Lactobacillus
  • 6.3 Bifidobacterium
  • 6.4 Saccharomyces
  • 6.5 Streptococcus
  • 6.6 Bacillus
  • 6.7 Enterococcus
  • 6.8 Other Ingredients

7 Global Gut Health & Probiotic Supplements Market, By Distribution Channel

  • 7.1 Introduction
  • 7.2 Pharmacies & Drug Stores
  • 7.3 Supermarkets & Hypermarkets
  • 7.4 Online Platforms
  • 7.5 Specialty Health Stores
  • 7.6 Convenience & Grocery Retailers
  • 7.7 Other Distribution Channels

8 Global Gut Health & Probiotic Supplements Market, By End User

  • 8.1 Introduction
  • 8.2 Adults
  • 8.3 Children
  • 8.4 Geriatric Population
  • 8.5 Veterinary Applications
  • 8.6 Pregnant & Lactating Women
  • 8.7 Other End Users

9 Global Gut Health & Probiotic Supplements Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Nestle Health Science
  • 11.2 Danone S.A.
  • 11.3 Chr. Hansen Holding A/S
  • 11.4 DuPont de Nemours Inc.
  • 11.5 Kerry Group plc
  • 11.6 Yakult Honsha Co. Ltd.
  • 11.7 Amway Corporation
  • 11.8 Bayer AG
  • 11.9 BioGaia AB
  • 11.10 DSM-Firmenich AG
  • 11.11 Probi AB
  • 11.12 Arla Foods amba
  • 11.13 General Mills Inc.
  • 11.14 NOW Foods
  • 11.15 Garden of Life LLC

List of Tables

  • Table 1 Global Gut Health & Probiotic Supplements Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Gut Health & Probiotic Supplements Market Outlook, By Product (2024-2032) ($MN)
  • Table 3 Global Gut Health & Probiotic Supplements Market Outlook, By Dietary Supplements (2024-2032) ($MN)
  • Table 4 Global Gut Health & Probiotic Supplements Market Outlook, By Functional Foods (2024-2032) ($MN)
  • Table 5 Global Gut Health & Probiotic Supplements Market Outlook, By Functional Beverages (2024-2032) ($MN)
  • Table 6 Global Gut Health & Probiotic Supplements Market Outlook, By Animal Feed Probiotics (2024-2032) ($MN)
  • Table 7 Global Gut Health & Probiotic Supplements Market Outlook, By Infant & Child Nutrition Products (2024-2032) ($MN)
  • Table 8 Global Gut Health & Probiotic Supplements Market Outlook, By Clinical Nutrition Products (2024-2032) ($MN)
  • Table 9 Global Gut Health & Probiotic Supplements Market Outlook, By Pet Nutrition & Companion Animal Products (2024-2032) ($MN)
  • Table 10 Global Gut Health & Probiotic Supplements Market Outlook, By Other Products (2024-2032) ($MN)
  • Table 11 Global Gut Health & Probiotic Supplements Market Outlook, By Ingredient (2024-2032) ($MN)
  • Table 12 Global Gut Health & Probiotic Supplements Market Outlook, By Lactobacillus (2024-2032) ($MN)
  • Table 13 Global Gut Health & Probiotic Supplements Market Outlook, By Bifidobacterium (2024-2032) ($MN)
  • Table 14 Global Gut Health & Probiotic Supplements Market Outlook, By Saccharomyces (2024-2032) ($MN)
  • Table 15 Global Gut Health & Probiotic Supplements Market Outlook, By Streptococcus (2024-2032) ($MN)
  • Table 16 Global Gut Health & Probiotic Supplements Market Outlook, By Bacillus (2024-2032) ($MN)
  • Table 17 Global Gut Health & Probiotic Supplements Market Outlook, By Enterococcus (2024-2032) ($MN)
  • Table 18 Global Gut Health & Probiotic Supplements Market Outlook, By Other Ingredients (2024-2032) ($MN)
  • Table 19 Global Gut Health & Probiotic Supplements Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 20 Global Gut Health & Probiotic Supplements Market Outlook, By Pharmacies & Drug Stores (2024-2032) ($MN)
  • Table 21 Global Gut Health & Probiotic Supplements Market Outlook, By Supermarkets & Hypermarkets (2024-2032) ($MN)
  • Table 22 Global Gut Health & Probiotic Supplements Market Outlook, By Online Platforms (2024-2032) ($MN)
  • Table 23 Global Gut Health & Probiotic Supplements Market Outlook, By Specialty Health Stores (2024-2032) ($MN)
  • Table 24 Global Gut Health & Probiotic Supplements Market Outlook, By Convenience & Grocery Retailers (2024-2032) ($MN)
  • Table 25 Global Gut Health & Probiotic Supplements Market Outlook, By Other Distribution Channels (2024-2032) ($MN)
  • Table 26 Global Gut Health & Probiotic Supplements Market Outlook, By End User (2024-2032) ($MN)
  • Table 27 Global Gut Health & Probiotic Supplements Market Outlook, By Adults (2024-2032) ($MN)
  • Table 28 Global Gut Health & Probiotic Supplements Market Outlook, By Children (2024-2032) ($MN)
  • Table 29 Global Gut Health & Probiotic Supplements Market Outlook, By Geriatric Population (2024-2032) ($MN)
  • Table 30 Global Gut Health & Probiotic Supplements Market Outlook, By Veterinary Applications (2024-2032) ($MN)
  • Table 31 Global Gut Health & Probiotic Supplements Market Outlook, By Pregnant & Lactating Women (2024-2032) ($MN)
  • Table 32 Global Gut Health & Probiotic Supplements Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.